Health claim

“Animal studies show that GLP‑1 agonists like semaglutide increase lifespan by up to 20%.”

Claim checked — strong evidenceLow risklongevity

Evidence Summary

Multiple well-designed studies consistently support this claim.

Research in mice has reported lifespan extensions of roughly 15‑20% with GLP‑1 receptor activation.

Extracted from

Could Ozempic Help You Live Longer? | Lifespan with Dr. David Sinclair - S2, Ep. 10

David Sinclair

The video discusses the potential of Ozempic (semaglutide) for extending lifespan, featuring insights from Dr. David Sinclair while examining current scientific evidence and limitations.

Watch breakdown →

Follow Longevity

Get an email when new longevity claims are evidence-checked — or when a verdict changes.

Free newsletter

Get the weekly evidence digest

5 claims reviewed each Friday. No hype.

Unsubscribe any time. No spam.

Educational content only. This page summarizes publicly available video content for informational purposes. It is not medical advice. Always speak with a licensed healthcare professional before making any medical decisions.

Animal studies show that GLP‑1 agonists like semaglutide increase lifespan by up to 20%. — Evidence Review — MenHealth Digest